Web site shows how a tumor grows in 3-D

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American


Ever wondered what it looks like when tumor cells grow inside the body? Drug maker Amgen is hoping to sate this morbid sort of Fantastic Voyage with a new Web site that takes viewers through the various stages of tumor angiogenesis in 3-D. Angiogenesis is a physiological process whereby new blood vessels grow from existing vessels. Although this process is a normal part of the body's ability to grow and heal itself, angiogenesis is also the path through which tumors transition from benign to malignant.

The site (also available in plain old 2-D) looks pretty good even without the paper 3-D glasses that Amgen supplies upon request. The graphics really come alive with the glasses though. The site depicts in painstaking detail a number of physiological phenomena, including how a tumor acquires a dedicated network of blood vessels to supply oxygen, remove waste and grow, and how proteins combine with receptors on the surface of blood vessels to stimulate growth.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


In other Amgen news, representatives plan to give a presentation June 7 at the American Society for Clinical Oncology meeting in Chicago to describe how the company's newly approved Prolia osteoporosis drug might help prostate cancer patients whose disease has spread to bone. Amgen created Prolia to help reduce the risk of bone fracture in post-menopausal women with osteoporosis, but further lab research indicated that the drug might also affect the process by which tumors penetrate bone, according to The Wall Street Journal.

Image courtesy of Amgen

Larry Greenemeier is the associate editor of technology for Scientific American, covering a variety of tech-related topics, including biotech, computers, military tech, nanotech and robots.

More by Larry Greenemeier

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe